skip to main content

H.R. 4439 (116th): Creating Hope Reauthorization Act


The text of the bill below is as of Sep 25, 2020 (Preprint (Suspension)).


G:\M\16\SUSPENSION\H4439_SUS.XMLXXXXXXXXXXXXXX9/28/2020 9:19XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 778579|1 [Discussion Draft] Suspend the Rules And Pass the Bill, H. R. 4439, with Amendments (The amendments strike all after the enacting clause and insert a new text and a new title) XXXXXX (Original Signature of Member) [DISCUSSION DRAFT]

I

116th CONGRESS

2d Session

H. R. 4439

IN THE HOUSE OF REPRESENTATIVES

September 20, 2019

(for himself, Mr. McCaul, Ms. Speier, Mr. Kelly of Pennsylvania, Mr. Engel, Mr. Bilirakis, Ms. Kelly of Illinois, Mr. Hudson, Mr. Rush, and Mr. Mullin) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.

1.

Short title

This Act may be cited as the Creating Hope Reauthorization Act.

2.

Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases

Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)(5)) is amended—

(1)

by striking December 11, 2020 each place it appears and inserting September 30, 2024; and

(2)

in subparagraph (B), by striking December 11, 2022 and inserting September 30, 2026.

Amend the title so as to read: A bill to amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases..